SKI Market

A+| A| A-|

Indian Indices

Sensex

77,569.39 827.57
( 1.08%)

Global Indices

Nasdaq

52,499.17 129.78
(0.25%)

Dow Jones

7,562.80 59.09
(0.79%)

Hang Seng

68,634.11 890.26
(1.31%)

Nikkei 225

10,472.08 -16.96
(-0.16%)

Forex

USD-INR

95.15 -0.21
(-0.22%)

EUR-INR

108.73 -0.26
(-0.24%)

GBP-INR

127.27 -0.11
(-0.09%)

JPY-INR

0.59 0.00
(-0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ultracab (India) Ltd

Industry : Cables - Power

BSE Code

ISIN Demat

Book Value()

538706

INE010R01023

7.5401052

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

15.5

87.67

EPS(TTM)

Face Value()

Div & Yield %

0.46

Back

Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter

Feb 09,2026

Net profit of Glaxosmithkline Pharmaceuticals rose 28.60% to Rs 295.62 crore in the quarter ended December 2025 as against Rs 229.88 crore during the previous quarter ended December 2024. Sales rose 9.67% to Rs 1041.26 crore in the quarter ended December 2025 as against Rs 949.42 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1041.26	949.42	10
OPM %	35.66	30.75	-
PBDT	402.27	326.90	23
PBT	381.95	308.10	24
NP	295.62	229.88	29

77,569.39 827.57 ( 1.08%)

52,499.17 129.78 (0.25%)

7,562.80 59.09 (0.79%)

68,634.11 890.26 (1.31%)

10,472.08 -16.96 (-0.16%)

95.15 -0.21 (-0.22%)

108.73 -0.26 (-0.24%)

127.27 -0.11 (-0.09%)

0.59 0.00 (-0.14%)